JP2021516991A5 - - Google Patents
Info
- Publication number
- JP2021516991A5 JP2021516991A5 JP2020568945A JP2020568945A JP2021516991A5 JP 2021516991 A5 JP2021516991 A5 JP 2021516991A5 JP 2020568945 A JP2020568945 A JP 2020568945A JP 2020568945 A JP2020568945 A JP 2020568945A JP 2021516991 A5 JP2021516991 A5 JP 2021516991A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- protein
- amino acid
- composition
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023222587A JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Cpgアンフィフィル及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862637824P | 2018-03-02 | 2018-03-02 | |
| US62/637,824 | 2018-03-02 | ||
| PCT/US2019/020398 WO2019169328A1 (en) | 2018-03-02 | 2019-03-01 | Cpg amphiphiles and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023222587A Division JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Cpgアンフィフィル及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021516991A JP2021516991A (ja) | 2021-07-15 |
| JP2021516991A5 true JP2021516991A5 (cg-RX-API-DMAC7.html) | 2022-03-09 |
| JP7883357B2 JP7883357B2 (ja) | 2026-07-01 |
Family
ID=67805576
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020568945A Active JP7883357B2 (ja) | 2018-03-02 | 2019-03-01 | Cpgアンフィフィル及びその使用 |
| JP2023222587A Pending JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Cpgアンフィフィル及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023222587A Pending JP2024045151A (ja) | 2018-03-02 | 2023-12-28 | Cpgアンフィフィル及びその使用 |
Country Status (20)
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018201090A1 (en) | 2017-04-28 | 2018-11-01 | Exicure, Inc. | Synthesis of spherical nucleic acids using lipophilic moieties |
| WO2018209270A1 (en) | 2017-05-11 | 2018-11-15 | Northwestern University | Adoptive cell therapy using spherical nucleic acids (snas) |
| KR102787353B1 (ko) | 2018-03-02 | 2025-03-26 | 엘리시오 테라퓨틱스, 인크. | 돌연변이 kras 서열 및 지질을 포함하는 화합물 및 이의 용도 |
| CA3183735A1 (en) * | 2020-06-26 | 2021-12-30 | Martin P. STEINBUCK | Compositions and methods for inducing an immune response against coronavirus |
| CN116507344A (zh) * | 2020-06-26 | 2023-07-28 | 伊莱西奥治疗有限公司 | 用于诱导针对冠状病毒的免疫应答的组合物和方法 |
| WO2023022973A2 (en) * | 2021-08-16 | 2023-02-23 | Elicio Therapeutics, Inc. | Compositions containing polynucleotide amphiphiles and methods of use thereof |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6168778B1 (en) * | 1990-06-11 | 2001-01-02 | Nexstar Pharmaceuticals, Inc. | Vascular endothelial growth factor (VEGF) Nucleic Acid Ligand Complexes |
| AU2001268427B2 (en) | 2000-06-16 | 2007-03-29 | Glaxosmithkline Intellectual Property Limited | Antibodies that immunospecifically bind to blys |
| US8771702B2 (en) * | 2001-03-26 | 2014-07-08 | The Trustees Of The University Of Pennsylvania | Non-hemolytic LLO fusion proteins and methods of utilizing same |
| JPWO2005001116A1 (ja) * | 2003-06-17 | 2006-08-24 | 明治乳業株式会社 | Toll様レセプター強制発現細胞の利用 |
| US9090673B2 (en) | 2003-12-12 | 2015-07-28 | City Of Hope | Synthetic conjugate of CpG DNA and T-help/CTL peptide |
| EP1776105A2 (en) * | 2004-07-18 | 2007-04-25 | Coley Pharmaceutical Group, Ltd | Methods and compositions for inducing innate immune responses |
| CN100508764C (zh) | 2005-02-05 | 2009-07-08 | 田景武 | 人参保鲜方法 |
| MX2009003398A (es) | 2006-09-27 | 2009-08-12 | Coley Pharm Gmbh | Analogos de oligonucleotidos cpg que contienen analogos t hidrofobos con actividad inmunoestimuladora mejorada. |
| EP2155889A4 (en) * | 2007-05-25 | 2010-06-16 | Centocor Ortho Biotech Inc | TOLL RECEPTOR 3 MODULATORS AND USES THEREOF |
| WO2010071852A2 (en) | 2008-12-19 | 2010-06-24 | University Of Florida Research Foundation, Inc. | Oligonucleotide micelles |
| ES2731343T3 (es) | 2009-05-19 | 2019-11-15 | Univ Miami | Composiciones, kits y métodos para presentación de antígenos in vitro, evaluación de eficacia de vacunas y evaluación de la inmunotoxicidad de productos biológicos y fármacos |
| US20120264810A1 (en) * | 2009-09-22 | 2012-10-18 | The University Of British Columbia | Compositions and methods for enhancing cellular uptake and intracellular delivery of lipid particles |
| ES2983470T3 (es) | 2010-03-19 | 2024-10-23 | Takeda Pharmaceuticals Co | Inhibidores del TFPI y métodos de uso |
| AU2012209274A1 (en) * | 2011-01-24 | 2013-09-12 | Anterios, Inc. | Nanoparticle compositions, formulations thereof, and uses therefor |
| BR112013030104A8 (pt) | 2011-05-25 | 2021-09-08 | Camurus Ab | Pré-formulação, processo para a formação de uma pré-formulação, método de tratamento cosmético, dispositivo de administração preenchido, e, kit |
| US20150044208A1 (en) | 2011-09-23 | 2015-02-12 | Technophage, Investigaçäo E Desenvolvimento Em Biotecnologia, Sa | Modified Albumin-Binding Domains and Uses Thereof to Improve Pharmacokinetics |
| US9694050B2 (en) | 2012-10-21 | 2017-07-04 | University Of Rochester | THY1 (CD90) as a novel therapy to control adipose tissue accumulation |
| KR102109188B1 (ko) | 2013-04-01 | 2020-05-11 | 삼성전자주식회사 | 양이온성 지질을 포함하는 온도민감성 리포좀 및 그의 용도 |
| AR095882A1 (es) * | 2013-04-22 | 2015-11-18 | Hoffmann La Roche | Terapia de combinación de anticuerpos contra csf-1r humano con un agonista de tlr9 |
| KR102100289B1 (ko) * | 2013-10-24 | 2020-04-13 | 주식회사 다이셀 | 은 나노 입자 함유 분산액의 제조 방법 및 은 나노 입자 함유 분산액 |
| AU2015314763A1 (en) * | 2014-09-11 | 2017-04-06 | Vedantra Pharmaceuticals, Inc. | Multilamellar lipid vesicle compositions and methods of use |
| US10940201B2 (en) * | 2015-09-30 | 2021-03-09 | Shionogi & Co., Ltd. | Nucleic acid derivative having immunostimulatory activity |
| KR20190082850A (ko) | 2016-11-30 | 2019-07-10 | 어드박시스, 인크. | 반복되는 암 돌연변이를 표적화하는 면역원 조성물 및 그것의 사용 방법 |
| EP3585428A1 (en) * | 2017-02-23 | 2020-01-01 | Alpha-o Peptides AG | Self-assembling protein nanoparticles encapsulating immunostimulatory nucleid acids |
| KR102787353B1 (ko) * | 2018-03-02 | 2025-03-26 | 엘리시오 테라퓨틱스, 인크. | 돌연변이 kras 서열 및 지질을 포함하는 화합물 및 이의 용도 |
-
2019
- 2019-03-01 US US16/977,185 patent/US12247052B2/en active Active
- 2019-03-01 UA UAA202006353A patent/UA128863C2/uk unknown
- 2019-03-01 EP EP19761384.7A patent/EP3758712B1/en active Active
- 2019-03-01 KR KR1020207028281A patent/KR102837422B1/ko active Active
- 2019-03-01 CN CN201980028828.9A patent/CN112203663A/zh active Pending
- 2019-03-01 MX MX2020009150A patent/MX2020009150A/es unknown
- 2019-03-01 CA CA3092693A patent/CA3092693A1/en active Pending
- 2019-03-01 CN CN202510413325.0A patent/CN120249290A/zh active Pending
- 2019-03-01 SG SG11202008432XA patent/SG11202008432XA/en unknown
- 2019-03-01 AU AU2019227988A patent/AU2019227988B2/en active Active
- 2019-03-01 PL PL19761384.7T patent/PL3758712T3/pl unknown
- 2019-03-01 MA MA052434A patent/MA52434A/fr unknown
- 2019-03-01 PT PT197613847T patent/PT3758712T/pt unknown
- 2019-03-01 BR BR112020017778-4A patent/BR112020017778A2/pt unknown
- 2019-03-01 WO PCT/US2019/020398 patent/WO2019169328A1/en not_active Ceased
- 2019-03-01 IL IL277101A patent/IL277101B2/en unknown
- 2019-03-01 MY MYPI2020004499A patent/MY209484A/en unknown
- 2019-03-01 DK DK19761384.7T patent/DK3758712T3/da active
- 2019-03-01 JP JP2020568945A patent/JP7883357B2/ja active Active
- 2019-03-01 ES ES19761384T patent/ES3035198T3/es active Active
- 2019-03-01 KR KR1020257023614A patent/KR20250111403A/ko active Pending
-
2020
- 2020-08-31 SA SA520420065A patent/SA520420065B1/ar unknown
-
2023
- 2023-12-28 JP JP2023222587A patent/JP2024045151A/ja active Pending
-
2025
- 2025-01-31 US US19/042,771 patent/US20250171507A1/en not_active Abandoned
- 2025-09-19 US US19/333,784 patent/US20260015390A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7504464B2 (ja) | 核酸ワクチン | |
| JP7330590B2 (ja) | 水痘帯状疱疹ウイルス(vzv)のための核酸ワクチン | |
| JP2021519595A (ja) | 新規rsv rna分子及びワクチン接種用組成物 | |
| JP2013532971A5 (cg-RX-API-DMAC7.html) | ||
| KR20180096591A (ko) | 광범위 인플루엔자 바이러스 백신 | |
| JP2024045151A (ja) | Cpgアンフィフィル及びその使用 | |
| JP2008529558A5 (cg-RX-API-DMAC7.html) | ||
| JP2015529678A5 (cg-RX-API-DMAC7.html) | ||
| JP2023532290A5 (cg-RX-API-DMAC7.html) | ||
| JP2010530362A5 (cg-RX-API-DMAC7.html) | ||
| WO2024140767A1 (zh) | 用于预防或治疗hpv感染相关疾病的多核苷酸分子 | |
| JP2022507373A5 (cg-RX-API-DMAC7.html) | ||
| RU2229307C1 (ru) | Композиция рекомбинантных белков, способ получения такой композиции, фармацевтический набор реагентов для иммунотерапии и профилактической вакцинации опухолевых заболеваний аногенитальной сферы, способ иммунотерапии и профилактической вакцинации на его основе | |
| JP2024512722A5 (cg-RX-API-DMAC7.html) | ||
| JP2011504108A5 (cg-RX-API-DMAC7.html) | ||
| JP2022513438A5 (cg-RX-API-DMAC7.html) | ||
| TH2001004949A (th) | Cpg แอมพิฟิลและการใช้สิ่งดังกล่าว | |
| RU2823677C2 (ru) | Cpg амфифилы и их применения | |
| WO2025092908A1 (zh) | 治疗HPV感染相关疾病的mRNA疫苗 | |
| CN118021957A (zh) | 一种编码抗禽流感H7N9病毒抗体的mRNA及其制法和应用 | |
| HK40045177B (en) | Cpg amphiphiles and uses thereof | |
| HK40045177A (en) | Cpg amphiphiles and uses thereof | |
| HK40043266A (en) | Cpg amphiphiles and uses thereof | |
| Wagner et al. | What is the future of targeted therapy in head and neck cancer? | |
| JP2014503174A5 (cg-RX-API-DMAC7.html) |